Join

Compare · FONR vs INMD

FONR vs INMD

Side-by-side comparison of Fonar Corporation (FONR) and InMode Ltd. (INMD): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both FONR and INMD operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
  • INMD is the larger of the two at $3.41B, about 33.4x FONR ($102.2M).
  • Over the past year, FONR is up 55.7% and INMD is up 1.0% - FONR leads by 54.6 points.
  • FONR has been more active in the news (3 items in the past 4 weeks vs 1 for INMD).
  • INMD has more recent analyst coverage (20 ratings vs 0 for FONR).
PerformanceFONR+55.66%INMD+1.02%
2025-04-28+0.00%2026-04-24
MetricFONRINMD
Company
Fonar Corporation
InMode Ltd.
Price
$18.84+0.16%
$14.40+0.14%
Market cap
$102.2M
$3.41B
1M return
+1.54%
+4.80%
1Y return
+55.66%
+1.02%
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NASDAQ
NASDAQ
IPO
1981
2019
News (4w)
3
1
Recent ratings
0
20
FONR

Fonar Corporation

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.

INMD

InMode Ltd.

InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. InMode Ltd. offers its products directly in United States, Canada, United Kingdom, Spain, India, Australia, and France, as well as through distributors in 47 countries. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.